Stress-activated Protein Kinases (JNK and p38/HOG) Are Essential for Vascular Endothelial Growth Factor mRNA Stability
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Stability of the vascular endothelial growth factor (VEGF) mRNA is tightly regulated through its 3'-untranslated region (3'-UTR). Here, we demonstrate that VEGF mRNA levels are increased by anisomycin, a strong activator of stress-activated protein kinases. Hence, VEGF mRNA induction is inhibited by SB202190, an inhibitor of JNK and p38/HOG kinase. Furthermore, VEGF mRNA expression is increased in cells that overexpress JNK and p38/HOG by an increase in its stability. We show by two different approaches that anisomycin exerts its effect on the VEGF mRNA 3'-UTR. First, by using an in vitro mRNA degradation assay, the half-life of the VEGF mRNA 3'-UTR region transcript was found to be increased when incubated with extracts from anisomycin-treated cells; and second, the 3'-UTR was also sufficient to confer mRNA instability to the Nhe3 (Na(+)/H(+) exchanger 3) heterologous reporter gene, and anisomycin treatment stabilized the chimeric mRNA (Nhe3 fused to the VEGF mRNA 3'-UTR). This chimeric mRNA is also more stable in cells overexpressing p38/HOG and JNK that have been stimulated by anisomycin. We show that such regulation is mediated through an AU-rich region of the 3'-UTR contained within a stable hairpin structure. By RNA electrophoretic mobility shift assays, we show that this region binds proteins specifically induced by anisomycin treatment. These findings clearly demonstrate a major role of stress-activated protein kinases in the post-transcriptional regulation of VEGF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“while overexpression of p38 and JNK also leads to VEGF expression elevation [ 51 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
Mitogen-activated protein kinase pathways
Robinson, M. J., & Cobb, M. H. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80061-0 · Cited by 2,474
On Finding All Suboptimal Foldings of an RNA Molecule
Zuker, M. (1989) · Science · doi:10.1126/science.2468181 · Cited by 2,005
Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Science · doi:10.1126/science.7839144 · Cited by 1,555
How Proteolysis Drives the Cell Cycle
King, R. W., Deshaies, R. J., Peters, J.-M., & Kirschner, M. W. (1996) · Science · doi:10.1126/science.274.5293.1652 · Cited by 1,273
Ellis, L., Clauser, E., Morgan, D. O., Edery, M., Roth, R. A., & Rutter, W. J. (1986) · Cell · doi:10.1016/0092-8674(86)90786-5 · Cited by 1,070
Research works printed but not linked: 2
- Chen, 1994, Mol. Cell. Biol., 14, 8471
- Robinson, 1997, Curr. Opin. Oncol., 9, 180
Cited by
Items 101–187 of 187
Targeting HDL in tumor microenvironment: New hope for cancer therapy
Zhao, T., Zhu, N., Shi, Y., Wang, Y., Zhang, C., Deng, C., Liao, D., & Li, Q. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30412 · Cited by 40
“VEGFR2 can also activate the p38 MAPK signaling pathway, which mediates endothelial cell migration, a key cellular process required for angiogenesis (Pagès et al., 2000).”
BackgroundDing, Y., Boguslawski, E. A., Berghuis, B. D., Young, J. J., Zhang, Z., Hardy, K., Furge, K., Kort, E. J., Frankel, A. E., Hay, R. V., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2229 · Cited by 36
“MKKs phosphorylate and activate MAPK (that is, ERK, p38 MAPK, and JNK), so measurements of phosphorylated 7 Supplementary material for this article is available at Molecular Cancer Therapeutics Online (http://mct.aacrjournals.org/).”
BackgroundInfluentialPost‐transcriptional regulation of VEGF expression by oxidised LDL in human macrophages
Salomonsson, L., Pettersson, S., Englund, M. C. O., Wiklund, O., & Ohlsson, B. G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01072.x · Cited by 36
Actin cytoskeleton differentially modulates NF-κB-mediated IL-8 expression in myelomonocytic cells
Kustermans, G., Mjiyad, N. E., Horion, J., Jacobs, N., Piette, J. G., & Legrand-Poels, S. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.017 · Cited by 38
Ortholan, C., Durivault, J., Hannoun‐Lévi, J., Guyot, M., Bourcier, C., Ambrosetti, D., Safe, S. H., & Pagès, G. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.021 · Cited by 40
Self-citationImportance of post-transcriptional regulation of chemokine genes by oxidative stress
Josse, C., Boelaert, J. R., Best‐Belpomme, M., & Piette, J. G. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600321 · Cited by 40
RNA-Binding Protein HuR Is Required for Stabilization of SLC11A1 mRNA and SLC11A1 Protein Expression
Xu, Y. Z., Marco, S. D., Gallouzi, I., Rola‐Pleszczynski, M., & Radzioch, D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8139-8149.2005 · Cited by 39
An, H. J., Lee, D., Lee, K. H., & Bhak, J. (2004) · BMC Genomics · doi:10.1186/1471-2164-5-97 · Cited by 33
“Growth factors, such as Gro-α [22] and the vascular endothelial factor [23] in humans, are also known to be associated with AREs.”
BackgroundTNF‐α expression is transcriptionally regulated by RANK ligand
Zou, W., Amcheslavsky, A., Takeshita, S., Drissi, H., & Bar‐Shavit, Z. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20127 · Cited by 36
“…cascade is involved in regulating mRNA stability via 30-UTRs of several mRNAs including IL-8, IL-6, c-Fos, GM-CSF, cyclooxygenase 2, vascular endothelial growth factor mRNA (Winzen et al., 1999; Lasa et al., 2000; Pages et al., 2000), and also via the 30-UTR of TNF-a mRNA (Brook et al., 2000).”
BackgroundXu, K., Kitchen, C. M., Shu, H. G., & Murphy, T. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705272200 · Cited by 30
Degousée, N., Angoulvant, D., Fazel, S. S., Stefanski, E., Saha, S., Iliescu, K., Lindsay, T. F., Fish, J. E., Marsden, P. A., Li, R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602815200 · Cited by 30
VEGF gene expression is regulated post‐transcriptionally in macrophages
Du, M., Roy, K., Zhong, L., Shen, Z., Meyers, H. E., & Nichols, R. C. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05106.x · Cited by 29
Chung, Y.-J., Jarvis, B. B., & Pestka, J. J. (2003) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390306363 · Cited by 29
“Protein synthesis inhibitors may repress mRNA degradation by depleting the specific 3′-UTR binding proteins leading to increased mRNA half-life and superinduction (Ohh & Takei, 1995; Pages et al., 2000; Roger et al., 1998).”
BackgroundPost-transcriptional regulation in Lymphocytes: The case of CD154
Vavassori, S., & Covey, L. R. (2009) · RNA Biology · doi:10.4161/rna.6.3.8581 · Cited by 28
Role of Cbl in Shear-Activation of PI 3-Kinase and JNK in Endothelial Cells
Miao, H., Yuan, S., Wang, Y., Tsygankov, A. Y., & Chien, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6750 · Cited by 27
MKK signaling and vascularization
Depeille, P., Ding, Y., Bromberg-White, J. L., & Duesbery, N. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210198 · Cited by 29
“MKK activity regulates VEGF expression at the transcriptional and post-transcriptional levels (Pages et al., 2000).”
BackgroundSanGiovanni, J. P., & Lee, P. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071239 · Cited by 26
“[13] The same team reported that VEGF mRNA induction is inhibited by JNK blockade with the drug SB202190.”
BackgroundCasein Kinase 2 Regulates the mRNA-destabilizing Activity of Tristetraprolin
Lee, W. H., Lee, H. H., Vo, M., Kim, H. J., Ko, M. S., Im, Y. C., Min, Y. J., Lee, B. J., Cho, W. J., & Park, J. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201137 · Cited by 26
Wang, S., Zhang, J., Theel, S., Barb, J. J., Munson, P. J., & Danner, R. L. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl386 · Cited by 29
“To date, the p38 MAPK signaling pathway has been implicated in stabilizing mRNA half-lives of more than 40 ARE genes (22), including cyclooxygenase 2 (23), TNFa (19), IL-3 (21), IL-8 (22,24), vascular endothelial growth factor (25) and p21/Waf1/Cip1 (26).”
BackgroundDedieu, S., Canron, X., Rezvani, H. R., Bouchecareilh, M., Mazurier, F., Sinisi, R., Zanda, M., Moenner, M., Bikfalvi, A., & North, S. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-19 · Cited by 25
“JNK is a known intermediate of VEGF-A mRNA and protein upregulation [48,49] and we previously showed that this pathway is also activated by amifostine [11].”
BackgroundConsequences and Utility of the Zinc-Dependent Metalloprotease Activity of Anthrax Lethal Toxin
Bromberg-White, J. L., Lee, C.-S., & Duesbery, N. S. (2010) · Toxins · doi:10.3390/toxins2051038 · Cited by 25
“The ERK pathway has been demonstrated to be critical in the control of VEGF expression [76] and to mediate VEGF-induced proliferation via the endothelial-specific receptor, VEGFR2 [77], while JNK and p38 have been shown to regulate VEGF expression [75].”
BackgroundHypoxic stabilization of mRNA is HIF-independent but requires mtROS
Fortenbery, G. W., Sarathy, B., Carraway, K., & Mansfield, K. D. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0112-2 · Cited by 23
Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts
Appledorn, D. M., Dao, K.-H. T., O’Reilly, S., Maher, V. M., & McCormick, J. J. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-13 · Cited by 22
“Therefore, Rac1 and Cdc42 may regulate both uPA and VEGF expression by altering JNK activity, and thereby regulating uPA and VEGF mRNA stability [26,27].”
BackgroundIida, K., Kawakami, Y., Sone, H., Suzuki, H., Yatoh, S., Isobe, K., Takekoshi, K., & Yamada, N. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01842-8 · Cited by 21
Faby, H., Hillenkamp, J., Roider, J. B., & Klettner, A. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2750-z · Cited by 24
p38 MAPK interacts with actin and modulates filament assembly during skeletal muscle differentiation
Khurana, A., & Dey, C. S. (2003) · Differentiation · doi:10.1046/j.1432-0436.2003.700604.x · Cited by 21
Headley, V. V., Tanveer, R., Greene, S. M., Zweifach, A., & Port, J. D. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000012841.03400.42 · Cited by 21
“In the case of IL-3, turnover is also modulated by p38 MAPK and by PI3K [36], and in the case of VEGF, p38/HOG is also involved [25].”
BackgroundTraumatic brain injury, diabetic neuropathy and altered-psychiatric health: The fateful triangle
Abou‐El‐Hassan, H., Dia, B., Choucair, K., Eid, S., Najdi, F., Baki, L., Talih, F. R., Eid, A. A., & Kobeissy, F. H. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.08.008 · Cited by 59
Xu, S. Q., Wu, Q., Guo, G. F., & Ding, X. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.015 · Cited by 20
Shin, J., Park, J., Kim, H.-J., Park, I., & Lee, H.-M. (2017) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2017.31.4415 · Cited by 20
Hypoxia and Hypoglycemia synergistically regulate mRNA stability
Carraway, K., Johnson, E. M., Kauffmann, T. C., Fry, N. J., & Mansfield, K. D. (2017) · RNA Biology · doi:10.1080/15476286.2017.1311456 · Cited by 21
“The discovery that glucose levels modulated the hypoxic response came from attempts to replicate previous studies which reported that VEGF mRNA half-life significantly increased in response to exposure to 1% oxygen.(29,31,33,40) However, intermittent success during preliminary investigations revealed that VEGF mRNA wa…”
ResultA genetic screen for yeast genes induced by sustained osmotic stress
Runner, V. M., & Brewster, J. L. (2003) · Yeast · doi:10.1002/yea.1019 · Cited by 19
“Interestingly, mammalian stress-activated protein kinases JNK and p38/HOG1 were recently shown to be essential to the regulation of vascular endothelial growth factor (VEGF) mRNA stability following the activation of cell stress (Pages et al., 2000).”
BackgroundThe Receptor for Urokinase Regulates TLR2 Mediated Inflammatory Responses in Neutrophils
Liu, G., Yang, Y., Yang, S., Banerjee, S., de Freitas, A., Friggeri, A., Davis, K. I., & Abraham, E. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025843 · Cited by 18
“Of note, p38 activation has been shown to regulate post-transcriptional events, such as TNF-a expression, in neutrophils and other cell populations [32,33,34,35].”
HIF‐1α regulates hypoxia‐induced EP1 expression in osteoblastic cells
Genetos, D. C., Lee, C. M., Wong, A., & Yellowley, C. E. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22119 · Cited by 18
“INFLUENCE OF MAPKS ON HYPOXIA-INDUCED EP1 EXPRESSION Induction of gene transcription in response to hypoxic conditions can involve the activation of MAPKs, including stress-activated protein kinase (SAPK/JNK), which is involved in stabilization of VEGF transcript [Pages et al., 2000].”
BackgroundERK5 Contributes to VEGF Alteration in Diabetic Retinopathy
Wu, Y., Zuo, Y., Chakrabarti, R., Feng, B., Chen, S., & Chakrabarti, S. (2010) · Journal of Ophthalmology · doi:10.1155/2010/465824 · Cited by 17
“Overexpression of p38 and JNK activation increased halflife of VEGF mRNA [36].”
BackgroundTherapeutic Targets of Type 2 Diabetes: an Overview
Banu, S., & Bhowmick, A. (2017) · MOJ Drug Design Development & Therapy · doi:10.15406/mojddt.2017.01.00011 · Cited by 17
Yu, Z., Tang, L., Chen, L., Li, J., Wu, W., & Chang-lin, H. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430334 · Cited by 14
Rousseau, S. (2011) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a001717.01 · Cited by 15
Regulation of ARE-mRNA Stability by Cellular Signaling: Implications for Human Cancer
Damgaard, C. K., & Lykke‐Andersen, J. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-31659-3_7 · Cited by 15
Tanabe, K., Dohi, S., Matsuno, H., Hirade, K., & Kozawa, O. (2003) · Anesthesiology · doi:10.1097/00000542-200305000-00017 · Cited by 13
Lin, C., Wang, Y., Chen, Y., Lin, Y.-L., Chen, B.-C., & Chen, M.-C. (2015) · Immunologic Research · doi:10.1007/s12026-015-8670-0 · Cited by 15
“Moreover, many signal transduction pathways have been associated with posttranscriptional regulation processes such as mRNA degradation [71–75].”
Li, J., Zhang, T., Meng, Y., Du, J., & Li, H. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000329967 · Cited by 12
Retinopathy of prematurity—promising newer modalities of treatment
Niranjan, H. S., Benakappa, N., Reddy, K. R. B. K., Shivananda, & Kamath, M. V. (2012) · Indian Pediatrics · doi:10.1007/s13312-012-0028-2 · Cited by 14
“In cell culture studies, a nonspecific JNK inhibitor was shown to affect VEGF mRNA stabilization [37].”
BackgroundYuan, Z., Gault, E. A., Campo, M. S., & Nasir, L. (2011) · Journal of General Virology · doi:10.1099/vir.0.033431-0 · Cited by 12
Perturbation of Mouse Retinal Vascular Morphogenesis by Anthrax Lethal Toxin
Bromberg-White, J. L., Boguslawski, E. A., & Duesbery, N. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006956 · Cited by 12
“Several studies point to a role for MKK signaling in controlling the release of VEGF and other angioproliferative factors from tumor cells in vitro [20,34,35,36,37,38].”
BackgroundCannizzo, C. M., Adonopulos, A. A., Solly, E. L., Ridiandries, A., Vanags, L. Z., Mulangala, J., Yuen, S. C. G., Tsatralis, T., Henriquez, R., Robertson, S. E. J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700617r · Cited by 12
“VEGFR2 also activates the p38 MAPK signaling pathway,whichmediates endothelial cellmigration, a critical cellular process required for angiogenesis (38).”
BackgroundZhao, D. S., Xue, H., Artemenko, I. P., & Jefcoate, C. R. E. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.08.006 · Cited by 13
Chong, D., Chen, Z., Guan, S., Zhang, T., Xu, N., Zhao, Y., & Li, C. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.03.009 · Cited by 14
New Vessel Formation and Aberrant VEGF/VEGFR Signaling in Acute Leukemia: Does it Matter?
de Bont, E. S. J. M., Neefjes, V., Rosati, S., Vellenga, E., & Kamps, W. A. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000015844 · Cited by 12
“Stress-activated protein kinases JNK and p38 MAPK have apparently no impact on the transcriptional activity of the VEGF promoter, but modulate the stability of VEGF mRNA [88].”
BackgroundQian, X.-J., He, J., Zhao, Y., & Lin, M. (2013) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000433950.01406.b3 · Cited by 10
“p38 MAPK pathway was crucial for both modulation and response to VEGF, and activation of p38 MAPK was critical in the stabilization of VEGF mRNA.(25,26) p38 MAPK pathway also played a pivotal role in the expression and activity of proinflammatory cytokines.”
BackgroundRoche, E., Lascombe, I., Bittard, H., Mougin, C., & Fauconnet, S. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.10.006 · Cited by 8
Roles of hypoxia in tumor progression and novel strategies for cancer treatment
Khan, B. D., Nhan, T. N. T., Chau, H. N. M., & Nhi, N. T. Y. (2022) · Biomedical Research and Therapy · doi:10.15419/bmrat.v9i10.774 · Cited by 9
Hirasawa, Y., Muramatsu, A., Suzuki, Y., & Nagamatsu, T. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj06010x · Cited by 8
Post-transcriptional Regulation of ura4 Gene Expression by Glucose in Schizosaccharomyces pombe
Kim, M. J., Kim, M. K., & Park, S. D. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15127-2 · Cited by 6
Muraleva, N. A., Александровна, Ж. А., Фурсова, А. Ж., & Kolosova, N. G. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924020020 · Cited by 9
Regulation of mRNA Turnover by Cellular Stress
Srikantan, S., & Gorospe, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00270-9 · Cited by 6
Fruttiger, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-78632-2_3 · Cited by 8
Saníger, M. L., Oya, R., Macías, D., Dominguez, J. N., Aránega, A. E., & Luque, F. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20801 · Cited by 8
“In addition it has been demonstrated that the activation of c-Jun kinase is crucial for the increase of VEGF mRNA stabilization mediated by stress protein kinases [Pages et al., 2000].”
BackgroundInfluentialCDKL1 variants affecting ciliary formation predispose to thoracic aortic aneurysm and dissection
Nauth, T., Philipp, M., Renner, S., Burkhalter, M. D., Schüler, H., Saygi, C., Händler, K., Siebels, B., Busch, A., Mair, T., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186287 · Cited by 5
Ogata, T. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01873.x · Cited by 5
“MAP kinases, such as p38 and JNK, reportedly participate in the mRNA stabilization of interleukin (IL)-2, IL-6, TNF-a, Cox-2 and vascular endothelial growth factor (Chen et al. 1998a, Ming et al. 1998, Miyazawa et al. 1998, Brook et al. 2000, Jang et al. 2000, Pages et al. 2000).”
BackgroundPlanel, S., Rataj, F., Feige, J., & Cherradi, N. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0466-8_17 · Cited by 5
Li, Z., Zhang, X., Sun, C., Fei, H., Li, Z., & Zhao, D. (2022) · Current Oncology · doi:10.3390/curroncol29110706 · Cited by 4
Miller, B. W., Hay, J. M., Prigent, S. A., & Dickens, M. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1316-9 · Cited by 4
Yao, Y., Kubota, T., Sato, K., Takeuchi, H., Handa, Y., & Matsukawa, S. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-6498-5 · Cited by 3
“It has been reported that p38 and JNK MAPKs regulate VEGF expression via mRNA stabilization [34].”
BackgroundResearch on Object Detection in Complex Scenarios Based on ASA ‐ YOLOv5
Lin, S., Deng, L., Zhang, H., Bi, L., Dong, J., Wan, D., Liu, H., & Liu, L. (2024) · IEEJ Transactions on Electrical and Electronic Engineering · doi:10.1002/tee.24249 · Cited by 2
“However, since HOG features do not have rotation invariance [13] and scale invariance [14], and are sensitive to noise, this method has low detection ability for occlude targets [15].”
Benítez-Garrido, J. P. D. J., Ibarra-Sánchez, A., Macías‐Silva, M., Molina, R., Padilla-Trejo, J. A., & González‐Espinosa, C. (2009) · The Open Allergy Journal · doi:10.2174/1874838400902010016 · Cited by 2
“It has been reported that activation of different MAPK, in particular p38, controls VEGF mRNA half life [29].”
BackgroundRole of ERK5 in Diabetic Vascular Complications
Wu, Y. (2012) · Scholarship@Western (Western University) · Cited by 1
UPR Activation in Cancer Cells: A Double-Edged Sword
Pereira, E. R., Preston, A. M., & Hendershot, L. M. (2012) · Springer eBooks · doi:10.1007/978-94-007-4351-9_17 · Cited by 1
Regulation of mRNA Turnover by Cellular Stress
Gorospe, M. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50674-4 · Cited by 1
Transcriptional Regulation of VEGFA by Unfolded Protein Response Signaling Pathway
Ghosh, R. (2010) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/0dfp-kp70
“VEGF mRNA is also stabilized by activation of the stress-activated protein kinase, p38, (193) which can be upregulated by the UPR.”
BackgroundInfluentialOn Microvascular Inflammation and Intestinal Leakage in Radiation Enteropathy
Röme, A. (2010) · Lund University Publications (Lund University)
MAEDA, Y. Y., Irié, T., Aida, T., & Tachikawa, T. (2004) · Shōwa Shigakkai zasshi/Showa Shigakkai zasshi · doi:10.11516/dentalmedres1981.24.196
Ishii, T., Sootome, H., Toyoda, H., Suda, M., Noumi, T., & Yamashita, K. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2007.063
“17 Since CREB/ATF1 can be phosphorylated by ERK1/2 and p38 through MSK1/MSK2 activation, 1 we examined whether the phosphosignaling cascade through MSK1/MSK2 was activated by anisomycin in HeLa cells.”
Mechanisms underlying cancer-induced bone pain
Sukhtankar, D. D. (2011) · UA Campus Repository (The University of Arizona)
Contribution of the Unfolded Protein Response to VEGF Expression
Pereira, E. R. (2012) · doi:10.21007/etd.cghs.2012.0243 · Cited by 1
Li, L. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0167674
“Studies have shown that p38 MAPK is not only involved in the increased production of angiogenetic factor VEGF by promoting mRNA stability in response to hypoxia (Pages et al., 2000) but is also required for VEGFR mediated cell motility resulting from enhanced actin”
Molecular Basis for Vascular Endothelial Growth Factor Expression in Tumor
Xie, K., & Yao, J. C. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8341-9_6
“unclear, the stress-activated protein kinases c-jun N-terminal kinase (JNK) and p38/HOG appear to be indispensable for the stabilization of VEGF mRNA [117].”
BackgroundInhibition isoforme spécifique des fonctions de la MAPK p38α par des fragments d’anticorps
Renaud, E. (2018) · theses.fr (ABES) · doi:10.70675/cb559ca8zb944z497aza929zccb0ad3fb527
Kumari, G. (2014) · Online Publication Service of Würzburg University (Würzburg University)
Ding, Y., Boguslawski, E. A., Berghuis, B. D., Young, J. J., Zhang, Z., Hardy, K., Furge, K., Kort, E., Frankel, A. E., Hay, R. V., et al. (2023) · doi:10.1158/1535-7163.c.6531159
Ding, Y., Boguslawski, E. A., Berghuis, B. D., Young, J. J., Zhang, Z., Hardy, K., Furge, K., Kort, E., Frankel, A. E., Hay, R. V., et al. (2023) · doi:10.1158/1535-7163.c.6531159.v1
Muraleva, N. A., Александровна, Ж. А., Фурсова, А. Ж., & Kolosova, N. G. (2024) · Biochemistry (Moscow) · doi:10.31857/s0320972524020024nfjge
Implication de p38 et p53 dans le mécanisme d’action du cetuximab dans le cancer colorectal
Marzi, L. (2014) · theses.fr (ABES) · doi:10.70675/985822a5zf0c2z4380zb466zb83f4b96b2d4
“p38 est impliquée dans la production [181] et la réponse au VEGF [182] en conditions hypoxiques ce qui va activer l’angiogenèse.”
BackgroundDiabetic retinopathy: shaped by the “hidden hand” of post-translational modifications
Xiao, R., & Zhang, M. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00973-x
“Conversely, the levels of VEGF can also be regulated by phosphorylation of above MAPK families [145, 146].”
A novel multi-target cancer therapy based on destabilization of short-lived mRNAs
Rataj, F. (2014) · theses.fr (ABES) · doi:10.70675/ca7f6363z2ad0z4ee7zab16z8ebd710c61ad
Metadata
- Authors
- Pagès, G., Berra, E., Milanini, J., Levy, A. P., & Pouysségur, J.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Technion – Israel Institute of Technology (IL)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 275
- Issue
- 34
- Pages
- 26484-26491
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2003506860
- Cited by
- 184
- References
- 52
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 2 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 9 · 2012: 7
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7373 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Kementerian Pendidikan Nasional
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- vascular endothelial growth factor, mRNA stability, 3' untranslated region, c-Jun N-terminal kinase, JNK, AU-rich region, AU-rich element-binding proteins, post-transcriptional regulation, anisomycin, mRNA degradation, hairpin structure
- MeSH terms
- Anisomycin, Enzyme Inhibitors, HeLa Cells, Humans, Imidazoles, Lymphokines, Nucleic Acid Conformation, Protein Synthesis Inhibitors, Pyridines, RNA, Messenger, Endothelial Growth Factors, Mitogen-Activated Protein Kinases, Saccharomyces cerevisiae Proteins, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.